DAWN Day One Biopharmaceuticals, Inc.
Healthcare$21.53+0.00%ClosedMarket Cap: $2.22B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$21.50
Target (Median)
$21.50
Target Range
$21.50 - $21.50
Upside from current price: -0.1%
Rating Distribution
0 Strong Buy0 Buy8 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-11 | JP Morgan | downgrade | Neutral | Overweight |
| 2026-03-10 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-03-09 | Wedbush | downgrade | Neutral | Outperform |
| 2026-03-06 | Jones Trading | downgrade | Hold | Buy |
| 2026-03-06 | Needham | downgrade | Hold | Buy |
| 2026-02-25 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-25 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-25 | Needham | maintain | Buy | Buy |
| 2025-11-24 | Needham | maintain | Buy | Buy |
| 2025-11-24 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.18 | $308.1M | 6 |
| Sun Dec 31 | $0.25 | $398.7M | 5 |
| Mon Dec 31 | $1.25 | $532.9M | 1 |
| Tue Dec 31 | $1.85 | $637.3M | 1 |